For help on how to get the results you want, see our search tips.
44 results
Medicine
Opinions on maximum residue limits Remove Opinions on maximum residue limits filter
Summaries of opinion Remove Summaries of opinion filter
Application type
Post-authorisation Remove Post-authorisation filter
-
List item
Summary of opinion: Ronapreve
casirivimab, imdevimab, opinion date: 26/04/2023, Positive, Last updated: 26/04/2023 -
List item
Summary of opinion: Trecondi
treosulfan, opinion date: 26/01/2023, Positive, Last updated: 27/01/2023 -
List item
Summary of opinion: Mircera
methoxy polyethylene glycol-epoetin beta, opinion date: 22/06/2023, Positive, Last updated: 23/06/2023 -
List item
Summary of opinion: NexGard Combo
esafoxolaner, eprinomectin, praziquantel, opinion date: 13/07/2023, Positive, Last updated: 14/07/2023 -
List item
Summary of opinion: Gumbohatch
avian infectious bursal disease vaccine (live), opinion date: 20/04/2023, Positive, Last updated: 21/04/2023 -
List item
Summary of opinion: Bravecto Plus
fluralaner, moxidectin, opinion date: 15/02/2023, Positive, Last updated: 17/02/2023 -
List item
Summary of opinion: Bravecto
fluralaner, opinion date: 15/06/2022, Positive, Last updated: 17/06/2022 -
List item
Summary of opinion: Nexgard Spectra
afoxolaner, milbemycin oxime, opinion date: 08/12/2022, Positive, Last updated: 09/12/2022 -
List item
Summary of opinion: Simparica Trio
sarolaner, moxidectin, pyrantel embonate, opinion date: 08/12/2022, Positive, Last updated: 09/12/2022 -
List item
Summary of opinion: Adcetris (new)
brentuximab vedotin, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Kaftrio (new)
ivacaftor, tezacaftor, elexacaftor, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Keytruda (new)
pembrolizumab, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Kalydeco (new)
ivacaftor, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Takhzyro (new)
lanadelumab, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Nordimet (new)
methotrexate, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Ryeqo (new)
relugolix, estradiol, norethisterone acetate, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Voxzogo (new)
vosoritide, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Olumiant (new)
baricitinib, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023 -
List item
Summary of opinion: Enhertu (new)
trastuzumab deruxtecan, opinion date: 14/09/2023, Positive, Last updated: 15/09/2023